K. Mazengia

CDR2L Antibodies: A New Player in Paraneoplastic Cerebellar Degeneration

C. Vedeler, A. Storstein, B. Haukanes, 2013, PloS one.

Expression of the onconeural protein CDR1 in cerebellum and ovarian cancer

C. Vedeler, M. Haugen, Torbjørn Kråkenes, 2018, Oncotarget.

Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke

Geir Egil Eide, H. Naess, G. Eide, 2015, Translational Stroke Research.

Onconeural antibodies: Improved detection and clinical correlations

J. Aarseth, S. E. Monstad, C. Vedeler, 2011, Journal of Neuroimmunology.

Avidity of onconeural antibodies is of clinical relevance

J. Aarseth, C. Vedeler, A. Storstein, 2013, Cancer Immunology, Immunotherapy.

Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke

H. Naess, G. Eide, C. Vedeler, 2015, Translational Stroke Research.

Paraneoplastic Cerebellar Degeneration

C. Vedeler, M. Haugen, C. Totland, 2021, Neurology: Neuroimmunology & Neuroinflammation.

Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease

P. Bakke, C. Vedeler, A. Storstein, 2014, Respirology.